Ownership

Jonathan Young - Chief Operating Officer at Akero Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: Chief Operating Officer
Stock Symbol: AKRO on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jonathan Young - trading volume in the past year for Akero Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-140K	100%	$28.66	-$4.02M
Net	-140K	-100%		-$4.02M

Holdings reported by Jonathan Young for Akero Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	216K	$7.12M	$32.94	Nov 1, 2024	Direct
Common Stoek	263K	$6.59M	$25.03	Apr 1, 2024	Direct
Common Stock	20K	$659K	$32.94	Nov 1, 2024	By CM Irrevocable Trust
Common Stock	20K	$659K	$32.94	Nov 1, 2024	By EA Irrevocable Trust
Common Stock	20K	$659K	$32.94	Nov 1, 2024	By JL Irrevocable Trust
Stock Option (Right to Buy)	0			Nov 1, 2024	Direct	Common Stock

Transactions reported by Jonathan Young for Akero Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.